Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Business
Mrinalika Roy

Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11

FILE PHOTO: A child is administered a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine, in San Jose, Costa Rica February 23, 2022. REUTERS/Mayela Lopez

A third dose of the COVID-19 vaccine from Pfizer Inc and BioNTech produced significant protection against the Omicron variant of the coronavirus in healthy children ages 5 to 11, the companies said on Thursday.

Blood serum analysis of 30 pediatric participants who received a booster dose in a study showed a 36-fold increase in Omicron neutralizing antibodies, the drugmakers said.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.